Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Disease Progression × regorafenib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 6 Colorectal Neoplasms 2 Unresectable Locally Advanced or Metastatic Solid Tumors 1 HER2-positive Colorectal Cancer 1 HER2 IHC3+ Advanced Colorectal Cancer 1 Gastrointestinal Stromal Tumors 1 Disease Progression 1 Cirrhosis, Familial, with Pulmonary Hypertension 1 Cholangiocarcinoma 1

Interventions

Anthropogenic Effects 2 regorafenib 1 cemiplimab 1 Pemetrexed 1 Paclitaxel 1 Drug Therapy 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07514455 2026-04-07

RECOMEND

Asan Medical Center

Phase 2 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡